Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260831.RA_teXceXldrnUH-pmT--cA__34GHmYd_HUGiJ74bzSLE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260831.RA_teXceXldrnUH-pmT--cA__34GHmYd_HUGiJ74bzSLE130_assertion type Assertion NP1260831.RA_teXceXldrnUH-pmT--cA__34GHmYd_HUGiJ74bzSLE130_head.
- NP1260831.RA_teXceXldrnUH-pmT--cA__34GHmYd_HUGiJ74bzSLE130_assertion description "[We previously found that expression of the transcription factor interferon regulatory factor 5 (IRF5) is significantly decreased as a breast lesion progresses from a non-malignant stage to ductal carcinoma in situ and is eventually lost in ~80% of invasive ductal carcinomas examined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260831.RA_teXceXldrnUH-pmT--cA__34GHmYd_HUGiJ74bzSLE130_provenance.
- NP1260831.RA_teXceXldrnUH-pmT--cA__34GHmYd_HUGiJ74bzSLE130_assertion evidence source_evidence_literature NP1260831.RA_teXceXldrnUH-pmT--cA__34GHmYd_HUGiJ74bzSLE130_provenance.
- NP1260831.RA_teXceXldrnUH-pmT--cA__34GHmYd_HUGiJ74bzSLE130_assertion SIO_000772 25649192 NP1260831.RA_teXceXldrnUH-pmT--cA__34GHmYd_HUGiJ74bzSLE130_provenance.
- NP1260831.RA_teXceXldrnUH-pmT--cA__34GHmYd_HUGiJ74bzSLE130_assertion wasDerivedFrom befree-2016 NP1260831.RA_teXceXldrnUH-pmT--cA__34GHmYd_HUGiJ74bzSLE130_provenance.
- NP1260831.RA_teXceXldrnUH-pmT--cA__34GHmYd_HUGiJ74bzSLE130_assertion wasGeneratedBy ECO_0000203 NP1260831.RA_teXceXldrnUH-pmT--cA__34GHmYd_HUGiJ74bzSLE130_provenance.